一、25分钟：一场教科书级的生命接力 媒体报道还原了那个紧张而有序的清晨：产妇李某突发大出血，一场多学科协同的"战斗"即刻打响。 "当时根本来不及多想，所有人启动紧急协作。"产科主任孙连华回忆道。在她的统筹下，抢救预案立即 启动。几乎在同一时间，麻醉科医生已携设备就位，新生儿科、重症医学科（ICU）团队同步收到预 警，并在产房外完成了接生台、ICU床位及监护设备的全部准备。 近日，中华网、新浪、网易、经济网、医药界等多家权威媒体，将目光共同投向了抚矿总医院一场惊心 动魄的25分钟母婴抢救。这场生命的速赢，不仅彰显了医护人员的专业，更引发了对现代医院"体系化 能力"的深入探讨。今天，我们借由这些报道，向您汇报并解读这份属于我们抚矿人的"底气"。 抢救现场，气道管理、紧急止血同步推进；沟通频道里，指令清晰简洁，流程无缝衔接。从第一针麻醉 药推注，到母婴被安全转入后续监护病房，全程仅用时25分钟。 这25分钟，跑赢的是死神，检验的却是一家医院环环相扣的系统能力。正如我院党委书记张兵在接受媒 体采访时指出的："真正的安全，不是单科的孤勇，而是多学科协同的合力。" 二、底气何来？深植于本色的协作基因 三、超越协作：红色 ...

睡眠医学中心是诊断睡眠障碍和研究睡眠医学的重要机构，但建设数量不足，且环境 设施和布局规范化设计未受足够重视。国民普遍存在睡眠问题，驱动睡眠医学中心行 业市场规模增长。2019 年至 2023 年，市场规模年复合增长率达 16.17%。未来，随着 睡眠健康理念普及、居民关注度提升及智能化水平升级，多领域企业入局，将推动睡 眠医学中心行业进一步发展，市场有望实现多元化。 1.2 睡眠医学中心定义 睡眠医学中心是通过多导睡眠监测进行睡眠障碍诊断和睡眠医学研究的重要医疗服务 机构。中国现有睡眠医学中心及临床睡眠检查室（睡眠监测室）的模式多种多样，大 多为单病种或专科睡眠检查室，部分为全病种睡眠检查室。大型医院的睡眠医学中心 在环境设施和布局方面初具规模，但多数医院睡眠医学中心的环境设施和布局规范化 设计仍未引起医院管理者及建筑设计师的足够重视。 1.3 市场演变 睡眠医学的研究起源于 19 世纪 70 年代，但当时对睡眠的认识相对有限，研究进展较 慢；1875 年，英国生理学家 Caton 用简易的电压感受器记录到动物脑电，代表着睡眠 监测技术的早期尝试的开始；1924 年，奥地利精神病学家 Hans Berger ...

Core Viewpoint - The incidence of multiple myeloma in China is increasing, with approximately 35,000 to 40,000 new cases diagnosed annually, primarily affecting the elderly population. Early detection and standardized treatment can lead to "functional cure" for many patients [4][7]. Group 1: Disease Overview - Multiple myeloma is a malignant blood disorder predominantly found in older adults, with a rising incidence due to aging and increased routine health check-ups [4]. - The disease progresses through three stages: Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Myeloma, and Active Myeloma, with symptoms often being non-specific and leading to misdiagnosis [5][6]. Group 2: Diagnosis and Early Detection - Approximately 60% to 70% of patients in large hospitals are misdiagnosed or undiagnosed at their first visit, highlighting the importance of early and accurate diagnosis [6]. - Regular health check-ups are crucial for early detection, especially for high-risk groups such as the elderly, those with a family history, obesity, or exposure to toxic substances [6][9]. Group 3: Treatment Advances - The median survival for multiple myeloma patients has improved from 2-3 years to 8-10 years due to advancements in treatment and the introduction of new drugs [7]. - Bispecific antibodies have shown an overall efficacy rate of 60% to 70%, providing new treatment options for relapsed/refractory patients [8]. Group 4: Multidisciplinary Collaboration - The management of multiple myeloma is evolving towards a long-term chronic disease model, necessitating multidisciplinary collaboration to address the complex health needs of patients [9]. - Comprehensive treatment plans require cooperation between various specialties, such as hematology, nephrology, and orthopedics, to ensure individualized care [9].

Core Insights - The article highlights the innovative daytime medical service model implemented in Liaocheng, which significantly improves the treatment experience for cancer patients by allowing them to receive care without lengthy hospital stays [1][2][3] Group 1: Service Model Innovation - Liaocheng has established a daytime radiotherapy and chemotherapy center, set to be operational by July 2024, focusing on optimizing medical resource allocation and enhancing patient experience [1] - The center employs a "four-in-one" service framework that includes process re-engineering, multidisciplinary collaboration, smart empowerment, and humanistic care to provide efficient and precise treatment [1][2] Group 2: Process Optimization - The city has integrated diagnostic and treatment processes, allowing patients to move from outpatient consultation to treatment planning in an average of just one working day [2] - The use of a unified appointment and intelligent scheduling system has reduced the average time patients spend in the hospital by over 2 hours per visit, achieving a "treat and go" model [1][2] Group 3: Multidisciplinary Collaboration - A multidisciplinary team, including specialists in radiation therapy, traditional Chinese medicine, nutrition, and psychology, collaborates to create personalized care plans for patients, ensuring a comprehensive management approach [2] - This integrated care model forms a closed-loop system of "treatment-rehabilitation-support," enhancing the overall patient experience [2] Group 4: Quality and Safety Measures - The city has incorporated daytime medical services into a unified quality control system, establishing mechanisms for quality checks and traceability throughout the treatment process [2] - Initiatives such as patient care stations and a 24-hour online communication platform have been implemented to ensure timely responses and support for patients [2] Group 5: Impact and Future Plans - Since its launch, the model has served thousands of cancer patients, achieving a treatment completion rate of over 95% and increasing bed turnover rates in related departments by over 30% [2] - The successful implementation of this model is being expanded to county-level healthcare facilities, enhancing regional cancer prevention and treatment capabilities [2][3] - Future plans include further development of daytime surgeries and chemotherapy, aiming to create a more efficient, precise, and patient-centered healthcare network [3]

Core Insights - The recent MDT academic conference focused on "New Advances in Chest Tumor Treatment and Clinical Practice," highlighting the importance of multidisciplinary collaboration in cancer diagnosis and treatment [1][2] Group 1: Conference Overview - The conference was co-hosted by Shandong Provincial Cancer Hospital, PLA 960 Hospital, and Tai'an Central Hospital, attracting experts from various medical institutions in the Tai'an region [1] - Keynote speakers emphasized the significance of the MDT model in enhancing patient quality of life and promoting personalized treatment [1] Group 2: Professional Frontiers - Professor Meng Xue presented on "New Forces in Chest Radiotherapy," discussing advancements in proton therapy, radiotherapy combined with immunotherapy, and FLASH radiotherapy [1] - Professor Han Shumei provided an in-depth interpretation of the "2025 NCCN Anti-Nausea Clinical Practice Guidelines," focusing on updates regarding high-emetic-risk drugs and optimization of anti-nausea protocols [1] Group 3: Clinical Case Discussions - Professor He Chengxiang shared clinical cases on "CT-guided Lung Cancer Cryoablation," demonstrating the efficacy of cryoablation technology in early-stage lung cancer and non-surgical candidates [2] - Professor Wan Long discussed a complex case of advanced lung adenocarcinoma with esophageal metastasis, exploring treatment strategies post-EGFR-TKI resistance and the practical application of Ivoris monoclonal antibody [2] - MDT teams from both PLA 960 Hospital and Shandong Provincial Cancer Hospital presented various typical cases, showcasing the advantages of multidisciplinary thinking [2] Group 4: Overall Impact - The conference covered a wide range of topics including radiotherapy, anti-nausea medication, minimally invasive interventions, and immunotherapy strategies, reflecting a patient-centered approach to individualized treatment [2] - The event served as a high-quality academic exchange platform for the oncology community in Tai'an, promoting the enhancement of multidisciplinary collaboration and overall treatment standards in the region [2]

Core Viewpoint - Lung cancer treatment and care are complex issues in the medical field, and hospitals can enhance service quality through multidisciplinary collaboration, precise management of elderly patients, and comprehensive case management [1] Group 1: Precision Care for Special Populations - The proportion of elderly lung cancer patients is increasing, presenting challenges due to their often poor physical condition and multiple comorbidities [2] - The hospital adopts a treatment philosophy that considers the patient as a whole person rather than just focusing on the tumor [2] - A comprehensive assessment is conducted by a team of specialists to evaluate organ function, physical status, nutritional level, cognitive function, and psychological state before treatment [2] - The hospital prioritizes treatment options with fewer side effects and more convenient administration, viewing lung cancer as a chronic condition requiring long-term management [2] Group 2: Comprehensive Case Management - Traditional medical models often face issues of fragmented care, especially for long-term cancer patients [3] - The hospital's tumor center implements "whole process case management" to provide continuous support from admission to post-discharge [3] - Case managers proactively engage with patients to clarify medical needs, coordinate appointments, and establish personalized health records [3] - A rapid response mechanism is in place to address any abnormal patient feedback, ensuring timely medical resource allocation [3] Group 3: Integrated Treatment Ecosystem - Lung cancer prevention and treatment are transitioning to a comprehensive management model that includes prevention, screening, diagnosis, treatment, and rehabilitation [4] - The hospital's "one-stop treatment ecosystem" integrates multidisciplinary collaboration, elderly management, and comprehensive case management [4] - The system focuses on both prevention and screening, utilizing community outreach and low-dose CT scans for high-risk populations [4] - The core treatment layer employs a multidisciplinary team (MDT) approach to provide seamless care from prevention to recovery [4] Group 4: Future Directions - The hospital plans to enhance the lung cancer prevention and treatment system through three main directions: smart healthcare, clinical research, and prevention rehabilitation [5] - Upgrading follow-up systems with intelligent reminders and data analysis for better decision-making [5] - Focusing on clinical research to address challenges related to lung cancer brain metastasis and developing a treatment database [5]

Core Viewpoint - The conference aims to enhance the capabilities of critical care services in the Zaozhuang region through collaboration and standardization in critical care practices [1][12]. Group 1: Conference Overview - The event was organized by the Shandong Provincial Big Data Research Association's Critical Care Medicine Branch, with participation from Shandong First Medical University Affiliated Provincial Hospital and Tengzhou Central People's Hospital [1]. - The conference adopted a hybrid format, focusing on the standardization and homogenization of critical care diagnosis and treatment [1]. Group 2: Key Speakers and Topics - Keynote speakers included Professor Zhang Jicheng, who emphasized the challenges faced by the emerging field of critical care medicine, such as talent shortages and insufficient equipment [5]. - Professor Zhang delivered a lecture on "Standards and Quality Improvement in the Treatment of Septic Shock," while Professor Bai Xue discussed "Improving the Initiation Rate of Enteral Nutrition within 48 Hours" [6]. - Professor Wang Feng shared insights on "Remote ICU: Exploring the Homogenization of Critical Care Diagnosis and Treatment" [6]. Group 3: Case Discussions and Collaborative Efforts - A case discussion segment featured challenging critical cases presented by physicians from both the provincial hospital and Tengzhou Central People's Hospital, highlighting the importance of multidisciplinary collaboration [9]. - The use of information technology for remote consultations was demonstrated, showcasing the potential for real-time monitoring and decision support in critical care [9][11]. Group 4: Future Implications - The establishment of a regional critical care center based on 5G and remote ICU technology is expected to enhance real-time monitoring and support for critical patients, contributing to timely and standardized high-level care [11]. - The conference represents a significant step in deepening grassroots support and promoting regional development in critical care medicine, injecting new momentum into the quality of medical services in the Zaozhuang area [12].

Core Viewpoint - The article emphasizes the growing obesity problem in China, highlighting the need for a national strategy to address obesity as a significant public health challenge, which is crucial for advancing the "Healthy China" initiative [4][5]. Group 1: Current Situation and Challenges - Over half of the adult population in China is classified as overweight or obese, with the growth rate of obese individuals surpassing that of overweight individuals [4]. - By 2030, medical expenses related to overweight and obesity are projected to account for approximately 22% of the total national healthcare costs [4]. - The number of patients undergoing weight loss and metabolic surgery in China has rapidly increased, with the first "ten thousand cases" achieved in three years and the second in just one year [5]. - Two main challenges in the development of weight loss and metabolic surgery in China are the need to expand quality medical resources and improve clinical specialty capabilities and safety standards [5]. Group 2: Initiatives and Recommendations - The "Blue Dragonfly" initiative was launched to promote scientific weight loss through education, hotline consultations, and assistance programs [4]. - Experts recommend a multidisciplinary approach to enhance the quality and safety of weight loss and metabolic surgery, focusing on disease-centered and weight loss-centered treatment strategies [5][8]. - There is a call for collaboration among government, health management departments, professional doctors, and patients to address weight management issues effectively [6]. Group 3: Clinical Insights and Trends - The prevalence of obesity is increasing, with over 70% of patients having a BMI over 30, and cases of severe obesity (BMI 50-60) becoming more common [7]. - There is a notable regional disparity in obesity rates, with higher rates in northern China compared to the south, and a significant gap in the availability of weight loss surgeries between coastal and inland regions [7]. - The article highlights the importance of integrating basic scientific research with industry practices, particularly in the study of gut microbiota and its relationship with obesity [9]. Group 4: Future Directions - The establishment of a comprehensive weight management system covering all age groups and medical disciplines is essential to reduce the incidence of obesity-related diseases [8]. - Recent advancements in weight loss medications have shown promising results, and there is a need for scientific and standardized use of these medications for optimal blood sugar management [8]. - The article suggests that addressing hypertension as a manifestation of obesity could provide new perspectives on obesity treatment, emphasizing lifestyle guidance and medication intervention [9].

Core Insights - NF1 is increasingly gaining attention in the medical community due to its high incidence in newborns and severe disease burden [1][2] - Early diagnosis and treatment are crucial for NF1 patients, with a focus on multidisciplinary collaboration for comprehensive management [1][3] Group 1: Disease Characteristics - NF1 is an autosomal dominant genetic disorder caused by mutations in the NF1 gene, affecting multiple systems and leading to significant disease burden [1] - Key clinical features include multiple café-au-lait spots, which are important for identification, along with other symptoms like freckles, iris hamartomas, skeletal deformities, and cognitive dysfunction [1][2] Group 2: Patient Statistics and Risks - Approximately 30% to 50% of NF1 patients develop plexiform neurofibromas (PN), with many children showing symptoms at birth [2] - Tumor growth is uncontrolled, with a growth rate of 35.1% per year in children aged 3-5 years, and 8% to 13% of tumors may undergo malignant transformation, with a five-year survival rate of less than 50% post-malignancy [2] Group 3: Diagnosis and Treatment - Diagnosis is primarily based on clinical symptoms, with genetic testing and imaging techniques like MRI used when symptoms are not apparent [2][3] - Treatment varies based on tumor location and impact on the patient, with options including laser treatment for superficial lesions and surgical removal for deep tumors, which pose significant surgical risks [3] Group 4: Management Challenges - Long-term follow-up and standardized management are essential for improving the quality of life for NF1 patients, facing challenges such as difficulties in drug reimbursement and insufficient pediatric medication availability [3] - Multidisciplinary involvement is necessary for effective diagnosis and treatment, requiring collaboration among various specialties including pediatrics, ophthalmology, dermatology, oncology, and surgery [3]

Core Viewpoint - The article emphasizes the rising incidence of urinary system tumors in China, particularly prostate, bladder, and kidney cancers, and highlights the importance of early screening, comprehensive treatment, and multidisciplinary collaboration in cancer prevention and control [1][2]. Group 1: Rising Incidence and Risk Factors - The incidence of urinary tumors is positively correlated with economic development and lifestyle changes, especially in coastal eastern regions of China [2] - High-risk groups include elderly males, individuals with a family history, long-term smokers, and those exposed to chemical pollutants [2] - Smoking is closely linked to kidney and bladder cancers, while poor drinking habits and the consumption of carbonated beverages may also contribute to urinary tumors [2] Group 2: Early Detection and Screening Recommendations - Early symptoms of urinary tumors are often subtle and easily overlooked, necessitating regular screenings starting at age 50 for the general population and at 45 for high-risk individuals [3] - Recommended screening methods include PSA testing for prostate cancer, ultrasound, and urinalysis for bladder and kidney cancers, with further diagnostic procedures as needed [3][4] Group 3: Innovations in Treatment - Advances in targeted therapies, immunotherapy, and robotic surgery are providing new hope for patients [5] - Genetic testing can guide precision medicine, such as using PARP inhibitors for prostate cancer patients with BRCA mutations and antibody-drug conjugates for bladder cancer patients with HER2 overexpression [5] - Robotic-assisted surgeries enhance precision in tumor removal while preserving patient quality of life [5] Group 4: Multidisciplinary Collaboration and Standardization - The multidisciplinary treatment (MDT) model is crucial for managing complex cases, requiring collaboration among various medical specialties [6] - The "China Cancer Integrated Diagnosis and Treatment Guidelines" provides a standardized framework for grassroots hospitals [6] - Shandong University Qilu Hospital promotes resource sharing and standardized treatment through academic exchanges and online consultations [6]